Correlation Between Visteon Corp and CERo Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Visteon Corp and CERo Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Visteon Corp and CERo Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Visteon Corp and CERo Therapeutics Holdings, you can compare the effects of market volatilities on Visteon Corp and CERo Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Visteon Corp with a short position of CERo Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Visteon Corp and CERo Therapeutics.

Diversification Opportunities for Visteon Corp and CERo Therapeutics

-0.21
  Correlation Coefficient

Very good diversification

The 3 months correlation between Visteon and CERo is -0.21. Overlapping area represents the amount of risk that can be diversified away by holding Visteon Corp and CERo Therapeutics Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on CERo Therapeutics and Visteon Corp is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Visteon Corp are associated (or correlated) with CERo Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of CERo Therapeutics has no effect on the direction of Visteon Corp i.e., Visteon Corp and CERo Therapeutics go up and down completely randomly.

Pair Corralation between Visteon Corp and CERo Therapeutics

Allowing for the 90-day total investment horizon Visteon Corp is expected to under-perform the CERo Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Visteon Corp is 10.42 times less risky than CERo Therapeutics. The stock trades about -0.13 of its potential returns per unit of risk. The CERo Therapeutics Holdings is currently generating about 0.1 of returns per unit of risk over similar time horizon. If you would invest  1.39  in CERo Therapeutics Holdings on November 7, 2024 and sell it today you would earn a total of  0.10  from holding CERo Therapeutics Holdings or generate 7.19% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy90.48%
ValuesDaily Returns

Visteon Corp  vs.  CERo Therapeutics Holdings

 Performance 
       Timeline  
Visteon Corp 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Visteon Corp has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest weak performance, the Stock's fundamental indicators remain sound and the latest tumult on Wall Street may also be a sign of longer-term gains for the firm shareholders.
CERo Therapeutics 

Risk-Adjusted Performance

14 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in CERo Therapeutics Holdings are ranked lower than 14 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unsteady basic indicators, CERo Therapeutics showed solid returns over the last few months and may actually be approaching a breakup point.

Visteon Corp and CERo Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Visteon Corp and CERo Therapeutics

The main advantage of trading using opposite Visteon Corp and CERo Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Visteon Corp position performs unexpectedly, CERo Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CERo Therapeutics will offset losses from the drop in CERo Therapeutics' long position.
The idea behind Visteon Corp and CERo Therapeutics Holdings pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.

Other Complementary Tools

CEOs Directory
Screen CEOs from public companies around the world
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Transaction History
View history of all your transactions and understand their impact on performance
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings